Search

everythinglearnresearchcommunity

for

Search:↓

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Baricitinib is an effective treatment for severe alopecia areata.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

An arthritis drug helped a person with severe hair loss regrow their hair.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Baricitinib improved hair loss and arthritis in a lupus patient.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.